261 related articles for article (PubMed ID: 22399508)
41. Extension of Prophylactic Surgery in Medullary Thyroid Carcinoma. Differences Between Sporadic and Hereditary Tumours According to Calcitonin Levels and Lymph Node Involvement.
Juez LD; Mercader E; Amunategui I; Febrero B; Rodríguez JM; Gómez-Ramírez J;
World J Surg; 2022 Apr; 46(4):820-828. PubMed ID: 35089388
[TBL] [Abstract][Full Text] [Related]
42. Nodal metastasis microRNA expression correlates with the primary tumour in MTC.
Gundara JS; Zhao JT; Gill AJ; Clifton-Bligh R; Robinson BG; Delbridge L; Sidhu SB
ANZ J Surg; 2014 Apr; 84(4):235-9. PubMed ID: 23072640
[TBL] [Abstract][Full Text] [Related]
43. [Lymphadenectomy in thyroid gland carcinoma--staging and therapy].
Pomorski L; Rybinski K
Zentralbl Chir; 1996; 121(6):455-8. PubMed ID: 8767330
[TBL] [Abstract][Full Text] [Related]
44. Medullary thyroid carcinoma: long-term outcomes of surgical treatment.
Abraham DT; Low TH; Messina M; Jackson N; Gill A; Chou AS; Delbridge L; Learoyd D; Robinson BG; Sidhu S; Sywak M
Ann Surg Oncol; 2011 Jan; 18(1):219-25. PubMed ID: 20878247
[TBL] [Abstract][Full Text] [Related]
45. Medullary thyroid carcinoma preferentially secreting procalcitonin.
Bugalho MJ; Madureira D; Domingues R; Pereira T; Cortez L
Thyroid; 2014 Jul; 24(7):1190-1. PubMed ID: 24684321
[No Abstract] [Full Text] [Related]
46. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
Esfandiari NH; Hughes DT; Yin H; Banerjee M; Haymart MR
J Clin Endocrinol Metab; 2014 Feb; 99(2):448-54. PubMed ID: 24276457
[TBL] [Abstract][Full Text] [Related]
47. [Lymph node involvement and prognosis in medullary cancers of the thyroid gland].
Mathonnet M; Cubertafond P; Teissier MP; Boutros-Toni F; Gainant A
Chirurgie; 1994-1995; 120(12):117-22. PubMed ID: 8746014
[TBL] [Abstract][Full Text] [Related]
48. Surgical management of sporadic medullary thyroid cancer.
Noullet S; Trésallet C; Godiris-Petit G; Hoang C; Leenhardt L; Menegaux F
J Visc Surg; 2011 Sep; 148(4):e244-9. PubMed ID: 21885365
[TBL] [Abstract][Full Text] [Related]
49. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer.
Machens A; Hoffmann F; Sekulla C; Dralle H
Endocr Relat Cancer; 2009 Dec; 16(4):1291-8. PubMed ID: 19726541
[TBL] [Abstract][Full Text] [Related]
50. Number of central lymph node metastasis for predicting lateral lymph node metastasis in papillary thyroid microcarcinoma.
Zeng RC; Zhang W; Gao EL; Cheng P; Huang GL; Zhang XH; Li Q
Head Neck; 2014 Jan; 36(1):101-6. PubMed ID: 23900787
[TBL] [Abstract][Full Text] [Related]
51. Prognostic impact of N staging in 715 medullary thyroid cancer patients: proposal for a revised staging system.
Machens A; Dralle H
Ann Surg; 2013 Feb; 257(2):323-9. PubMed ID: 22968075
[TBL] [Abstract][Full Text] [Related]
52. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.
Gimm O; Ukkat J; Dralle H
World J Surg; 1998 Jun; 22(6):562-7; discussion 567-8. PubMed ID: 9597929
[TBL] [Abstract][Full Text] [Related]
53. Selective lateral compartment neck dissection for thyroid cancer.
Welch K; McHenry CR
J Surg Res; 2013 Sep; 184(1):193-9. PubMed ID: 23816244
[TBL] [Abstract][Full Text] [Related]
54. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.
Machens A; Schneyer U; Holzhausen HJ; Dralle H
J Clin Endocrinol Metab; 2005 Apr; 90(4):2029-34. PubMed ID: 15634717
[TBL] [Abstract][Full Text] [Related]
55. Occult multifocal papillary thyroid microcarcinoma presenting as a supraclavicular mass containing anaplastic thyroid carcinoma.
Deutschmann M; Khalil M; Bhayana S; Chandarana S
JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):415-8. PubMed ID: 23599079
[TBL] [Abstract][Full Text] [Related]
56. Multi- and Unifocal Thyroid Microcarcinoma: Are There Any Differences?
Kaliszewski K; Zubkiewicz-Kucharska A; Wojtczak B; Strutyńska-Karpińska M
Adv Clin Exp Med; 2016; 25(3):485-92. PubMed ID: 27629737
[TBL] [Abstract][Full Text] [Related]
57. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis.
Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558
[TBL] [Abstract][Full Text] [Related]
58. Medullary thyroid carcinoma: management of lymph node metastases.
Moley JF
J Natl Compr Canc Netw; 2010 May; 8(5):549-56. PubMed ID: 20495084
[TBL] [Abstract][Full Text] [Related]
59. Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome.
Alzumaili B; Xu B; Spanheimer PM; Tuttle RM; Sherman E; Katabi N; Dogan S; Ganly I; Untch BR; Ghossein RA
Mod Pathol; 2020 Sep; 33(9):1690-1701. PubMed ID: 32313184
[TBL] [Abstract][Full Text] [Related]
60. Prediction of lateral lymph node metastases in medullary thyroid cancer.
Machens A; Hauptmann S; Dralle H
Br J Surg; 2008 May; 95(5):586-91. PubMed ID: 18300267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]